Table 3. Development of superovulated oocytes using Cetorelix in aged mice.
| Treatment | No. of females | No. of oocytes | No. of 2-cell embryos (%) | No. of embryos transferred | No. of offspring (%) |
|---|---|---|---|---|---|
| Control | 9 | 42 | 39 (92.9) | 39 | 22 (56.4) |
| Cetrorelix 3 times | 10 | 98 | 95 (96.9) | 60 | 35 (58.3) |
| Cetrorelix 7 times | 10 | 87 | 77 (88.5) | 56 | 29 (51.8) |
Sampling of each experimental group was repeated 3 times.